Seelos Therapeutics, Inc. (SEELQ) — Financial Flexibility Index
Seelos Therapeutics, Inc. (SEELQ) has a Financial Flexibility Index of -0.03x as of June 2024. Free cash flow of $-972.00K (operating CF $-972.00K minus capex $0.00) represents 0% of total liabilities ($30.51 Million). Also explore Seelos Therapeutics, Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Seelos Therapeutics, Inc. Financial Flexibility Index (2020–2023)
Historical Financial Flexibility Index trend for Seelos Therapeutics, Inc. across 4 annual periods. See SEELQ equity to assets ratio to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Seelos Therapeutics, Inc. (2020–2023)
Year-by-year free cash flow to debt coverage for Seelos Therapeutics, Inc.. For the full company profile including market capitalisation, see Seelos Therapeutics, Inc. market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.61x | $-23.91 Million | $-23.91 Million | $38.93 Million | ▲ +66.7% |
| 2022 | -1.85x | $-61.60 Million | $-61.60 Million | $33.36 Million | ▲ +1.3% |
| 2021 | -1.87x | $-48.99 Million | $-48.99 Million | $26.18 Million | ▼ -33.5% |
| 2020 | -1.40x | $-20.91 Million | $-20.91 Million | $14.92 Million | — |